TrialAfrican health sciences2013

24-Month adherence, tolerance and efficacy of once-a-day antiretroviral therapy with didanosine, lamivudine, and efavirenz in African HIV-1 infected children: ANRS 12103/12167.

H Hien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.